Mr. Andrew Tsaran is a Managing Partner of Cukierman Investment House in China. Andrew has over 20 years of hands-on experience in different hi-tech industries and the financial sector. In the past, Andrew has held executive management positions at several prominent companies such as Resmed (NYSE: RMD), Flight Medical (TLV:ILX), , Curatia, Infinity Equity Funds, MobilEye (acquired by Intel) and Life Watch(SIX: LIFE). Lately, Andrew served as General Manager Asia Pacific of Shekel Brainweigh, leading the company through IPO process and turnover.
Andrew earned B.Sc. and M.Sc. from the Technion – Israel Institute of Technology.
Andrew attended the Business School of ECUST – East China University of Technology, majoring in an International MBA.
